Health care industry

FILE - In this July 10, 2018 file photo, bottles of prescription medicines ride on a conveyor belt at a pharmacy warehouse in Florence, N.J. According to a report released on Tuesday, Jan. 8, 2018, annual spending by the U.S. health industry on ads and promotions has reached $30 billion. That includes advertisements for prescription drugs that were shown 5 million times on TV and elsewhere in 2016. That’s a huge increase in 20 years and just part of broad health industry efforts to promote drugs, devices, lab tests and even new hospitals. (AP Photo/Julio Cortez, File)
January 08, 2019 - 1:29 pm
Ads for prescription drugs appeared 5 million times in just one year, capping a recent surge in U.S. medical marketing, a new analysis found. The advertisements for various medicines showed up on TV, newspapers, online sites and elsewhere in 2016. Their numbers soared over 20 years as part of broad...
Read More
January 07, 2019 - 2:11 pm
WASHINGTON (AP) — The Supreme Court seemed inclined Monday to side with drugmaker Merck & Co. in a dispute over the warning label on its bone-strengthening drug Fosamax. The justices heard arguments in a case involving hundreds of people who sued the Kenilworth, New Jersey-based drug company,...
Read More
FILE - This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. Eli Lilly is buying Loxo Oncology for about $8 billion as it continues to broaden its cancer treatment efforts. Loxo Oncology Inc. is a biopharmaceutical company focused on the development and commercialization of highly selective medicines for patients with genomically defined cancers. (AP Photo/Darron Cummings, File)
January 07, 2019 - 6:49 am
Eli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities. Loxo Oncology could launch a drug next year and targets an abnormality that occurs in several tumor types, including some lung and thyroid...
Read More
CAPTION CORRECTS DATE TO FEB. 4, 2009 In this Feb. 4, 2009 photo, a view of the exterior of the University Hospital in Enkoping, Sweden, Friday, Jan. 4, 2019. Officials say a Swedish hospital has reported a suspected case of the deadly Ebola virus, adding the patient has been isolated. Region Uppsala, which oversees several hospitals and medical clinics north of Stockholm, says a test had been carried out on the patient who was not identified, adding a result would be available late Friday, Jan. 4, 2019. (Henrik Montgomery/TT News Agency via AP)
January 05, 2019 - 4:21 am
HELSINKI (AP) — Swedish health officials say a suspected Ebola case reported by a hospital has turned out to be a false alarm with tests carried out on the unidentified patient showing no signs of the deadly virus. Medical authorities said late Friday that the young male patient was admitted to an...
Read More
FILE - In this June 15, 2005, file photo, a sign stands in front of a Bristol-Myers Squibb building in a Lawrence Township, N.J. Bristol-Myers Squibb is buying Celgene in a cash-and-stock deal valued at about $74 billion. (AP Photo/Mel Evans, File)
January 03, 2019 - 5:00 pm
SUMMIT, N.J. (AP) — Bristol-Myers Squibb is spending $74 billion on fellow drugmaker Celgene in a deal aimed at stocking the combined company's development pipeline with cancer, immunology and cardiovascular treatments. Bristol would gain the cancer treatment Revlimid in the cash-and-stock deal...
Read More
FILE - This April 20, 2009 file photo, shows the British pharmaceuticals firm GlaxoSmithKline in London. Drugmakers GlaxoSmithKline and Pfizer are merging their healthcare divisions, creating a business with combined sales of 9.8 billion pounds ($12.7 billion). British-based Glaxo will own 68 percent of the joint venture, while U.S.-based Pfizer will own the remaining 32 percent stake. (AP Photo/Sang Tan, File)
December 19, 2018 - 12:18 pm
Drugmakers GlaxoSmithKline and Pfizer plan to merge their consumer health businesses into what will be the world leader in sales of nonprescription medicines such as pain relievers, vitamins and cold remedies. The new joint venture would have with combined annual sales of $12.7 billion (9.8 billion...
Read More
FILE- In this Dec. 12, 2018, file photo trader Gregory Rowe works at the New York Stock Exchange, Wednesday, Dec. 12, 2018, in New York. The U.S. stock market opens at 9:30 a.m. EST on Monday, Dec. 15. (AP Photo/Mark Lennihan, File)
December 17, 2018 - 3:13 pm
NEW YORK (AP) — The latest on developments in financial markets (all times local): 4 p.m. The Dow Jones Industrial Average plunged 500 points, its second straight drop of that size and its fourth big decline this month. Longtime market favorites like Microsoft and Amazon took heavy losses Monday...
Read More
December 12, 2018 - 11:22 am
ST. PAUL, Minn. (AP) — Minnesota lawmakers are considering steps they could take to rein in the soaring cost of insulin, which one couple says has become so expensive that their diabetic son could no longer afford it and died. State Sen. Matt Little convened an informal discussion at the state...
Read More
In this Aug. 16, 2010 file photo a nurse looks on from a window of the Giulesti hospital following a fire that left 5 newborn babies dead. Romanian health authorities on Friday, Nov. 30, 2018, temporarily closed the maternity hospital in the capital after over a dozen babies born there recently were diagnosed with a drug-resistant superbug. The Health Ministry said the hospital would stop admissions after the newborns were recently diagnosed with antibiotic-resistant Staphylococcus aureus. (AP Photo/Vadim Ghirda, File)
December 10, 2018 - 6:38 am
BUCHAREST, Romania (AP) — Romanian authorities say the number of babies diagnosed with a drug-resistant superbug at a maternity hospital in the capital has risen to 39. Raluca Alexandru, spokeswoman for Giulesti Maternity hospital, closed Nov. 30 due to the outbreak, on Monday said tests have...
Read More
FILE - In this May 25, 2018 file photo members of the supervisory board sit in front of the company logo during the annual shareholders meeting of German chemical giant Bayer AG in Bonn, Germany. Bayer said Thursday, Nov 29, 2018 it will cut 12 000 jobs, most of them in Germany. (AP Photo/Martin Meissner, file)
November 29, 2018 - 8:13 am
BERLIN (AP) — German pharmaceutical giant Bayer AG says it's cutting 12,000 jobs worldwide as it seeks to reduce costs. The Leverkusen-based company said Thursday that details of the cuts to its 118,200-stong workforce would be worked out in coming months but that "a significant number" of the...
Read More

Pages